Articles tagged with Peptides
Researchers at the University of Queensland have discovered a new class of blood pressure-regulating peptides in vampire bat venom that could revolutionize treatments for various medical conditions. The peptides are selective in their mode of action, reducing side effects compared to existing therapies.
Researchers at Purdue University have discovered two peptides that selectively activate beneficial cellular pathways without causing unwanted side effects. These peptides are being investigated in preclinical studies for their ability to regulate dietary intake and have shown promising results.
Researchers isolated a peptide, named SP6, from spirulina extract that can dilate blood vessels and effectively lower blood pressure in animal models. The peptide acts positively on the natural mechanisms regulating endothelial function, which is often impaired in hypertensive patients.
Scientists have elucidated the formation mechanism of amyloid-β substances, causative agents of Alzheimer's disease. They found that Aβ peptides tend to aggregate at hydrophilic/hydrophobic interfaces, forming β-hairpin structures that facilitate intermolecular hydrogen bonding.
Galanin-like peptide (GALP) plays a key role in regulating feeding behavior and energy metabolism. Recent research has shown that GALP administration leads to decreased respiratory quotient, indicating accelerated lipid metabolism.
A new algorithm that combines experimental data with machine learning reduces the time needed to find optimal peptide sequences, allowing for faster discovery and synthesis. This method has the potential to revolutionize how peptides are designed and could lead to breakthroughs in materials science, chemistry, and medicine.
Researchers at PNNL and UCLA verify Gibbs' theory for materials forming row by row, bypassing the nucleation barrier. This discovery provides clues for designing microelectronics and bodily tissues with better control and efficiency.
A new study has identified a specific peptide that directly binds to the ion-channel CFTR, impairing its function and triggering cellular stress and inflammation. This interaction can be inhibited by a potentiator of CFTR, which may offer protection against gluten-induced intestinal symptoms.
Researchers develop method to identify tumor-specific factors in blood that can elicit a protective immune response, potentially leading to an effective vaccine against cancer. The technique relies on peptide arrays and frameshift mutations, which have been shown to be more effective stimulators of immune response than point mutations.
Researchers develop new method for selectively binding proteins to nanoparticles using co-assembling points of contact, promising applications in diagnostics and medicine. The method has potential for treating diseases such as Alzheimer's by dissolving amyloid aggregates.
Researchers have determined the three-dimensional structure of the PTH-1 receptor, a protein fragment involved in bone loss. This breakthrough enables the development of new drugs that may slow down or reverse osteoporosis without its current treatment's disadvantages.
Researchers discovered that signal peptides can inhibit glutamate receptor trafficking, leading to potentiation of synaptic responses. The study provides new insights into the molecular mechanisms underlying glutamate receptor trafficking and its role in neurological disorders.
Researchers at IRB Barcelona develop peptide shuttle using scorpion venom to transport drugs across blood-brain barrier, improving efficacy for neurological treatments. The miniCTX3 peptide shows great efficiency in carrying compounds of different nature across the BBB.
Research with mice suggests exercise strengthens resolve against drug addiction by changing peptide levels in the brain. Re-exposure to drug-related cues affects exercise and sedentary mice differently.
Researchers identify significant impact of genetic diversity on peptide binding to HLA molecules, with implications for understanding HIV elite control and drug hypersensitivity. The study may also aid in the development of personalized vaccines.
Scientists at IOCB Prague have discovered a previously unknown passive mechanism by which positively charged short peptides can penetrate cells. This process is based on membrane fusion induced by the transported peptides and shares the same mechanistic basis as known processes in neurons during nerve impulses.
A novel technology for profiling protein turnover and degradation has been developed, revealing distinct evidence of a signature pattern in autoimmune disorders. The technique focuses on degraded proteins, providing clues about the state of protein monitoring and potentially leading to better diagnostic techniques.
Scientists have successfully explained the structure and function of docking domains in peptide natural products. This breakthrough allows researchers to redesign docking domain interactions, modulating the product spectrum of a rhabdopeptide-synthesizing NRPS. The discovery has promising implications for creating new substances.
Researchers develop structure-disrupting peptides to target bacterial proteins' structural core, reducing likelihood of resistance development. The study finds promising results in inhibiting multidrug-resistant bacteria growth and treating gonococcal infections.
Researchers have discovered a genetic risk factor for Alzheimer's disease and related dementias, which may lead to new treatments. Humanin, a naturally occurring mitochondrial peptide, decreases with age and is associated with an increased risk of diseases linked to older age.
Researchers at University of Notre Dame discover that T-cell receptors can be more cross-reactive than previously thought, increasing the challenge of developing effective immunotherapies. This finding highlights the need to reassess predictions for building models for therapy and recognizing targets.
Researchers analyzed ant venom from a tropical species and identified over 2,800 venom peptides, including 37 full-length peptide precursors called myrmicitoxins. The peptides showed sequence similarities with those produced by other insects, suggesting they evolved from ancestral genes.
A recent study suggests that specific immune system peptides could influence brain activity and drug cravings, offering a potential partner in the fight against opioid addiction. The research focuses on targeting these peptides to reduce cravings in human patients.
Researchers found that positively charged calcium ions enhance Ti-1 peptide adhesion to titanium surfaces while limiting access for Ti-2 peptide, revealing principles for designing peptides with tunable affinity to titanium applications.
Rutgers researchers discovered a primordial peptide with two types of amino acids and a metal cluster similar to iron-sulfur minerals, suggesting it could have emerged spontaneously on early Earth. The short peptide may have served as a catalyst for life-producing chemistry.
Researchers from Far Eastern Federal University have discovered a new group of Kunitz-type peptides in Heteractis magnifica sea anemones, which exhibit neuroprotective properties. The peptides inhibit the development of inflammations and reduce levels of active oxygen forms that cause cell damage.
Scientists develop peptide hydrogel that stimulates new blood vessel and dental pulp growth in teeth after root canals. The material aims to preserve more of the existing dental pulp and help grow new tissue, making the procedure less invasive.
Researchers have mapped how peptides reduce infection and inflammation by deactivating toxic substances formed in the process. The study reveals that these peptides form a C-shaped structure which enables the capturing and inactivation of lipopolysaccharides, a necessary part of our immune defence system.
Scientists at TUM have discovered a new class of designed macrocyclic peptides that are highly potent inhibitors of amyloid formation, which could be an alternative to current antibody-based approaches. The researchers are now planning further investigations to verify their effectiveness in in vivo models.
Researchers synthesized tetrapeptide PAGY and its analogues using solid phase peptide synthesis, screening their antioxidant properties. The results showed that PSGY exhibited the highest DPPH inhibition activity, while modifications in amino acid sequences increased or decreased antioxidant activity.
Researchers have discovered peptides that can inhibit autophagy in living animals, providing a promising treatment against various diseases. The peptides are derived from giant ankyrins and can be used to occlude autophagy spatiotemporally.
Researchers at the University of British Columbia have created a matchmaking service to pair peptides with antibiotics, increasing treatment success rates against antimicrobial resistant bacteria. Seven combinations were identified that worked better than antibiotics alone, offering up to a 100-fold improvement.
The new molecules are formed by a chain of 7 amino acids, each composed of only two different amino acids. These peptides have numerous applications, including generating electrical nanoconductors and fibrillar mini enzymes capable of acting as catalysts in the formation of organic nanomaterials.
Amyloid peptides prevent CamKII from participating in synaptic plasticity, leading to synapse loss and cognitive deficiencies. Researchers aim to understand the molecular mechanism behind amyloid aggregate interactions with CamKII to develop potential treatments for early Alzheimer's disease.
Researchers developed a peptide-infused dressing that promotes dermal cell adhesion and proliferation, accelerating wound closure and tissue regeneration in diabetic mice. The dressing showed significant benefits compared to control treatments.
Researchers have discovered a novel treatment that reduces the deadly immune response triggered by trauma, which can lead to systemic inflammatory response syndrome and sepsis. The drug, deformylase, neutralizes N-formyl peptides released from damaged mitochondria, improving survival rates in animal models.
Researchers have discovered that beef peptides can block bitter taste receptors on the tongue, potentially leading to improved flavors in food and medicine. The most effective peptides were produced through enzymatic hydrolysis using trypsin and pepsin enzymes.
A Northwestern-led synthetic biology research team has developed a new biotech technique called GlycoSCORES that promises to accelerate research into protein therapies. The technique uses cell-free protein synthesis, protein glycosylation, and mass spectrometry to rapidly screen sequences for making glycoproteins.
Beta peptides can self-assemble into robust biomaterials when placed inside other organic molecules. A new study has expanded their capabilities, allowing bioengineers to create more flexible materials for tissue engineering and biomedicine.
Researchers at EPFL have developed a new peptide format called double-bridged peptides that can bind to any disease target with high affinity and stability. By creating an enormous diversity of peptide architectures, they were able to isolate high-affinity binders to important protein targets, including kallikrein and interleukin-17.
Researchers successfully created chirality-evolving gold nanoparticles with amino acids and peptides. The new synthesis method enables color modulation by controlling light polarization, paving the way for future displays.
Researchers have designed and synthesized molecules that can interact together to assemble complex molecular structures at the nanoscale. By mimicking biological self-assembly processes, chemists can learn new methods of chemical synthesis for nano/micro-structures.
Researchers at La Jolla Institute for Immunology develop a peptide vaccine that induces protective T cells and decreases plaque size in atherosclerotic mice. The vaccine targets the 'bad cholesterol' protein and expands a class of protective T cells, curbing inflammation.
Researchers at the University of Washington have designed a convenient and natural product that uses proteins to rebuild tooth enamel and treat dental cavities. The new technology restores mineral structure found in native tooth enamel, enabling daily use as part of preventive dental care routine.
Researchers at RIKEN Center for Sustainable Resource Science discovered a small hormone, CLE25, that moves from roots to leaves to prevent water loss. The study shows how CLE25 induces ABA synthesis and closes pores in leaf surfaces.
A team of plant geneticists at Cold Spring Harbor Laboratory identified a protein receptor on stem cells that issues different instructions depending on the peptide fragment activating it. This multi-functional receptor has important implications for boosting crop yields, particularly in crops like corn and rice.
Researchers from Hong Kong University of Science and Technology identified a family of D-stereospecific peptidases (DRPs) that are involved in combating widely-distributed antibiotics. These genes are phylogenetically widespread and pose a significant threat to treating antibiotic-resistant bacteria.
Scientists have discovered a beet compound that may help alleviate Alzheimer's symptoms by inhibiting the misfolding of proteins in the brain. The study found that betanin, a compound in beet extract, reduced oxidation of proteins associated with the disease, potentially slowing its progression.
A new bioinformatics analysis method has been developed to study viral infections, revealing over 500 different proteins and peptides, including 200 previously unknown to science. This discovery improves the identification of translation events and opens up new possibilities to understand the effects of viral infections on the organism.
A new biocompatible catalyst selectively oxygenates and degrades amyloid-β peptide under near-infrared light irradiation, reducing its pathogenic properties. The catalyst is applicable for treating peripheral amyloid diseases and Alzheimer's disease.
Researchers discovered that a hydrogel developed by the Rice University lab exhibits significant therapeutic properties, rapidly infiltrating host cells and promoting healing. The hydrogel can be delivered through a syringe and degrades over six weeks, leaving behind healthy tissue.
Researchers at ETH Zurich have made a groundbreaking discovery that protein amyloids can self-replicate, challenging the long-held RNA hypothesis as the origin of life. The findings suggest that early life forms may have used amyloids as information carriers and catalytic units.
Researchers at Technical University of Munich have developed a strategy for designing peptides that can be administered orally, overcoming the major challenge of stability and absorption. This breakthrough simplifies the creation of peptide medications, potentially offering new treatments for various diseases.
Researchers at Joslin Diabetes Center discovered that four viruses can produce insulin-like hormones that bind to human insulin receptors and stimulate cellular signaling. This finding opens up a new field of study in microbial endocrinology, potentially revealing biological mechanisms behind diabetes, autoimmune disease, and cancer.
Researchers have identified the crucial role of peptide uptake in Borrelia burgdorferi's viability and ability to infect mammals. Blocking this process could lead to novel therapeutic interventions for Lyme disease.
Scientists have identified a new family of peptides in wasp venom that can control insect behavior, which may also help develop Parkinson's disease treatments. The peptides, called ampulexins, were found to immobilize cockroaches, and further research aims to identify cellular targets for potential treatment applications.
Researchers at University of Toronto have developed technology for creating durable disease-fighting molecules that can last longer in the body, reducing frequent drug injections. Mirror-image versions of existing drugs, such as GLP1 and PTH, have been created using computational approach, showing longer-lasting effects on cells.
Researchers at the University of Würzburg have discovered how honeybees manage to visit flowers at the right time and communicate this information to other bees. The study found that a specific peptide called PDF plays a central role in regulating circadian clocks, transferring day-night information to brain areas that control complex ...
A Brazilian research team discovered a cellular signaling pathway involved in both the immune response to Zika and neurogenesis, a process of new neuron formation. The study found that peptides from the renin-angiotensin system played a key role in this pathway.
Researchers create virus-like nanoparticles that can detect and process environmental inputs, producing controllable outputs. The modified viruses can display multiple peptides on their surface, enabling efficient delivery of protein- or peptide-based therapeutics to specific cells or tissues.